Make Visible: Chronic Illness Explored cover image

#29 Long Covid: what has six years taught us?

Make Visible: Chronic Illness Explored

00:00

TLC prioritizes four therapeutic studies

Breen outlines four trials: Reverse LC antiviral, low‑dose naltrexone, GLP‑1 agents, and stellate ganglion block pilot.

Play episode from 29:04
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app